PALAZURE Trademark

Trademark Overview

On Wednesday, November 17, 2010, a trademark application was filed for PALAZURE with the United States Patent and Trademark Office. The USPTO has given the PALAZURE trademark a serial number of 85178692. The federal status of this trademark filing is ABANDONED - NO STATEMENT OF USE FILED as of Monday, June 16, 2014. This trademark is owned by Glaxo Group Limited. The PALAZURE trademark is filed in the Pharmaceutical Products category with the following description:

Pharmaceutical preparations and substances for the treatment of damaged skin and tissue; Pharmaceutical preparations and substances for the treatment of infectious diseases, blood disorders, pain, inflammation, sepsis, alopecia, obesity and cognitive disorders; Pharmaceutical preparations and substances for the treatment of viral, metabolic, endocrine, musculoskeletal, cardiovascular, cardiopulmonary, genitourinary, sexual dysfunction, oncological, hepatological, ophthalmic, respiratory, neurological,gastrointestinal, hormonal, dermatological, psychiatric and immune system related diseases and disorders; Vaccines
palazure

General Information

Serial Number85178692
Word MarkPALAZURE
Filing DateWednesday, November 17, 2010
Status606 - ABANDONED - NO STATEMENT OF USE FILED
Status DateMonday, June 16, 2014
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing4000 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, March 15, 2011

Trademark Statements

Goods and ServicesPharmaceutical preparations and substances for the treatment of damaged skin and tissue; Pharmaceutical preparations and substances for the treatment of infectious diseases, blood disorders, pain, inflammation, sepsis, alopecia, obesity and cognitive disorders; Pharmaceutical preparations and substances for the treatment of viral, metabolic, endocrine, musculoskeletal, cardiovascular, cardiopulmonary, genitourinary, sexual dysfunction, oncological, hepatological, ophthalmic, respiratory, neurological,gastrointestinal, hormonal, dermatological, psychiatric and immune system related diseases and disorders; Vaccines

Classification Information

International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateSunday, November 21, 2010
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History

Party NameGlaxo Group Limited
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
AddressBrentford, Middlesex TW89GS
GB
Party NameGlaxo Group Limited
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressGreenford, Middlesex UB60NN
GB

Trademark Events

Event DateEvent Description
Monday, June 16, 2014ABANDONMENT NOTICE MAILED - NO USE STATEMENT FILED
Monday, June 16, 2014ABANDONMENT - NO USE STATEMENT FILED
Wednesday, October 16, 2013NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Tuesday, October 15, 2013EXTENSION 5 GRANTED
Wednesday, October 9, 2013EXTENSION 5 FILED
Wednesday, October 9, 2013TEAS EXTENSION RECEIVED
Tuesday, May 7, 2013NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Saturday, May 4, 2013EXTENSION 4 GRANTED
Monday, April 15, 2013EXTENSION 4 FILED
Friday, May 3, 2013CASE ASSIGNED TO INTENT TO USE PARALEGAL
Monday, April 15, 2013TEAS EXTENSION RECEIVED
Monday, March 25, 2013APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
Monday, March 25, 2013TEAS CHANGE OF OWNER ADDRESS RECEIVED
Monday, March 25, 2013ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Monday, March 25, 2013TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Friday, November 2, 2012NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Thursday, November 1, 2012EXTENSION 3 GRANTED
Monday, October 29, 2012EXTENSION 3 FILED
Monday, October 29, 2012TEAS EXTENSION RECEIVED
Tuesday, May 8, 2012NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Monday, May 7, 2012EXTENSION 2 GRANTED
Friday, April 13, 2012EXTENSION 2 FILED
Thursday, May 3, 2012CASE ASSIGNED TO INTENT TO USE PARALEGAL
Friday, April 13, 2012TEAS EXTENSION RECEIVED
Wednesday, November 2, 2011NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Monday, October 31, 2011EXTENSION 1 GRANTED
Monday, October 31, 2011EXTENSION 1 FILED
Monday, October 31, 2011TEAS EXTENSION RECEIVED
Tuesday, May 10, 2011NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Tuesday, March 15, 2011OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, March 15, 2011PUBLISHED FOR OPPOSITION
Thursday, February 10, 2011LAW OFFICE PUBLICATION REVIEW COMPLETED
Friday, February 4, 2011ASSIGNED TO LIE
Wednesday, February 2, 2011APPROVED FOR PUB - PRINCIPAL REGISTER
Wednesday, February 2, 2011ASSIGNED TO EXAMINER
Sunday, November 21, 2010NEW APPLICATION OFFICE SUPPLIED DATA ENTERED IN TRAM
Saturday, November 20, 2010NEW APPLICATION ENTERED IN TRAM

Related Keywords

palazure pharmaceutical treatment disorders preparations substances diseases ophthalmic respiratory hepatological oncological